Oxygen-induced Retinopathy in the Rat. Vitamins C and E As Potential Therapies
Overview
Affiliations
Oxygen-induced retinopathy (OIR) was produced by subjecting newborn albino rats to a 60% oxygen atmosphere for 14 days before they were killed and retinal analysis was done. The extent of OIR was measured by estimating the severity of retinal vasoobliteration in ink-perfused flat-mounted retinas. This was done with the aid of a digitizing camera and an image-analysis system designed to create binary images of the retinal blood vessels. Retinal levels of several antioxidant molecules also were measured. Alpha-tocopherol and ascorbic acid were reduced in oxygen-exposed rats by 34% and 20%, respectively, compared with room air-raised control animals. Retinal glutathione reductase, S-transferase, and peroxidase showed no differences between oxygen-treated and -untreated rats. Attempts to increase the newborn rats' retinal ascorbic acid by administering daily subcutaneous injections (5 g/kg body weight) to the mother rats were unsuccessful. However, the level of retinal alpha-tocopherol of newborn rats could be altered by dietary manipulation of the mothers. The mothers were fed diets containing either 1 g alpha-tocopherol acetate/kg food or none, starting 21-25 days before the birth of their litters and lasting throughout the exposure period. This treatment resulted in three- to fourfold differences in the retinal alpha-tocopherol levels of the pups. The combination of dietary and oxygen treatments also resulted in significant differences in retinal glutathione peroxidase activity, with the vitamin E-deprived, oxygen-exposed group having highest levels. Newborn rats both supplemented with and deprived of alpha-tocopherol had less vasoobliteration than did those nursed by mothers fed rat chow.
Kim S, Sonmez K, Swan R, Campbell J, Ostmo S, Paul Chan R Sci Rep. 2021; 11(1):4966.
PMID: 33654115 PMC: 7925531. DOI: 10.1038/s41598-021-83552-y.
Why is Zeaxanthin the Most Concentrated Xanthophyll in the Central Fovea?.
Widomska J, SanGiovanni J, Subczynski W Nutrients. 2020; 12(5).
PMID: 32392888 PMC: 7284714. DOI: 10.3390/nu12051333.
Tsang J, Liu J, Lo A Int J Mol Sci. 2019; 20(17).
PMID: 31484463 PMC: 6747312. DOI: 10.3390/ijms20174321.
The progress of prophylactic treatment in retinopathy of prematurity.
Zhang H, Wang X, Xu K, Li X Int J Ophthalmol. 2018; 11(5):858-873.
PMID: 29862189 PMC: 5957042. DOI: 10.18240/ijo.2018.05.24.
Advances in understanding and management of retinopathy of prematurity.
Hartnett M Surv Ophthalmol. 2016; 62(3):257-276.
PMID: 28012875 PMC: 5401801. DOI: 10.1016/j.survophthal.2016.12.004.